Marker Therapeutics
MRKR
MRKR
32 hedge funds and large institutions have $5.04M invested in Marker Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$207K |
| 2 |
Renaissance Technologies
New York
|
+$53.5K |
| 3 |
Squarepoint
New York
|
+$53.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38.2K |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$804K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$53.3K |
| 3 |
EGM
Engineers Gate Manager
New York
|
-$51.1K |
| 4 |
Millennium Management
New York
|
-$50.1K |
| 5 |
LPL Financial
San Diego,
California
|
-$8K |
